Watch CBS News
Pfizer is requesting FDA authorization of its antiviral COVID-19 pill. The company's study found it is nearly 90% effective in cutting hospitalizations and deaths from the virus. Meanwhile, at least 20 states are experiencing upticks in infections. Infectious disease physician at the University of Michigan Dr. Payal Patel joins CBSN's Elaine Quijano to discuss the latest pandemic news.
The CDC reports over 1 million children ages 5 to 11 have received the first dose of Pfizer's pediatric vaccine. This comes as several states and New York City begin expanding booster eligibility to all adults. Director of vaccine research at Cincinnati Children's Hospital, Dr. Robert Frenck, joins CBSN's Elaine Quijano with a look at the day's pandemic news.
"The bulk of the evidence at that time did not support this policy proposal," Anne Schuchat, a former CDC deputy director, told congressional investigators.
The CDC and WHO are warning that there is an increased risk of a measles outbreak.
The Food and Drug Administration authorized a smaller dose of Pfizer's COVID-19 vaccine for children ages 5 to 11 on Tuesday. By Wednesday morning, parents were lining up to get their kids vaccinated. While some are choosing to wait, many parents are relieved they can finally give their kids some protection from COVID. Michael George reports.
The White House has released more details of the COVID-19 vaccine mandate for large companies. Skyler Henry reports from the Washington, and CBS News reporter Alexander Tin joined "Red and Blue" to discuss the requirement and other headlines in the fight against the coronavirus pandemic.
According to new data from the Centers for Disease Control and Prevention, people who are already fully vaccinated are showing up to get their COVID booster shot in greater numbers than those not yet vaccinated. This comes after the FDA on Wednesday granted emergency use authorization to vaccine booster shots from Moderna and Johnson & Johnson, clearing the way for millions to be eligible for extra protection against the coronavirus. Elise Preston has the latest.
The CDC authorized the expansion of booster shots to certain Moderna and Johnson & Johnson recipients Thursday, while also allowing eligible Americans to get a different booster than the initial shot they received months ago. Meg Oliver reports on the updated guidelines for nearly 100 million people now eligible for an extra dose of protection against the coronavirus.
Every school-age child in the U.S. is now eligible for COVID-19 shots after Pfizer's mini dose received the green light from the Centers for Disease Control and Prevention. Janet Shamlian takes a look.
The CDC unanimously recommended Pfizer's low dose COVID-19 vaccine for kids ages 5 to 11. Drugstores like CVS and Walgreens are already setting up appointments, but some parents are hesitant about getting their kids vaccinated. Family medicine physician and CEO of CFP Physicians Group Dr. Adrian Burrowes joins CBSN's Lana Zak to discuss.
Children ages 5 to 11 are now eligible for a lower-dose version of Pfizer's COVID-19 vaccine, after the CDC issued its recommendation on Tuesday. Dr. Julie Morita, the executive vice president of the Robert Wood Johnson Foundation, joined CBSN to discuss the latest coronavirus headlines.
Roughly 28 million grade-school age children are now eligible to receive the COVID-19 vaccine. The CDC recommended the low-dose version of Pfizer’s vaccine for kids between the ages of 5 and 11. Dr. Rashmi Jain, a concierge pediatrician and founder of BabiesMD.com, joins CBSN to discuss the recommendation.
With the CDC's recommendation, 28 million American children between the ages of 5 to 11 years old are now eligible to receive Pfizer's COVID-19 vaccine at a lower dosage.
The decision follows a unanimous vote by the agency's outside vaccine experts to recommend Pfizer's COVID-19 vaccine for younger children.
The Centers for Disease Control and Prevention is on the verge of reccomending the Pfizer COVID-19 vaccination for children between the ages of 5 and 11. Dr. Julie Morita, executive vice president at the Robert Wood Johnson Foundation, joined CBSN to discuss the vaccination and what this means for parents.
Centers for Disease Control and Prevention advisers voted to recommend Pfizer's COVID-19 vaccine for children as young as 5. Meg Oliver shares more.
The FDA has authorized Pfizer's COVID-19 vaccine for kids aged 5 to 11. Clinical trials found the smaller dose is 91% effective against the virus. Executive vice president of the Robert Wood Johnson Foundation Dr. Julie Morita joined CBSN's Lana Zak to discuss.
The Food and Drug Administration and the Centers for Disease Control and Prevention are expected to authorize a reduced-dose Pfizer vaccine for kids aged 5 to 11 in the next week. CBS News reporter Max Bayer joins CBSN's Tanya Rivero for an update.
An FDA advisory panel is endorsing a reduced-dose version of Pfizer's COVID-19 vaccine for kids aged 5 to 11. If the FDA and CDC sign off, shots for kids could be available by late next week. CBS News' Debra Alfarone reports, and then Dr. Stanley Perlman, a member of the FDA panel, joins CBSN's Tanya Rivero to discuss to vaccine and what it means for children and parents.
The Centers for Disease Control and Prevention has updated its guidance for people with compromised immune systems, saying they can now get a fourth Pfizer or Moderna COVID-19 shot.
Pfizer's COVID-19 vaccine for children is one step closer to being approved after an FDA advisory committee voted unanimously to recommend lower doses of the shot for kids aged 5 to 11. CBS News correspondent Janet Shamlian reports on the panel's decision. Then, Dr. Ben Weston, an associate professor in the department of emergency medicine at the Medical College of Wisconsin, joins CBSN's Elaine Quijano to discuss the latest.
Millions of children under the age of 12 could be eligible for a COVID-19 vaccine in just a matter of weeks. Moderna says a low dosage of its coronavirus vaccine is safe and appears effective in kids age 6 to 11. Meanwhile, an FDA committee will meet Tuesday to discuss whether to approve Pfizer's vaccine for children. CBS News correspondent Meg Oliver has the latest. Then, Dr. Shikha Jain, assistant professor of medicine at the University of Illinois Chicago, joins CBSN's Elaine Quijano to discuss.
A CDC panel has voted in favor of the Johnson and Johnson and Moderna COVID-19 vaccine booster shots. Pending approval from the agency's director, millions of people could soon line up for an additional dose. CBS News' Meg Oliver breaks down the decision. Then, critical care physician Dr. Lakshmana Swamy joins CBSN's Lana Zak with his analysis.
A CDC advisory panel is recommending booster doses of both Moderna's and Johnson & Johnson's COVID-19 vaccines. Now CDC Director Dr. Rochelle Walensky will decide whether to accept or revise the committee's recommendations. Meg Oliver has more.
Fresh, whole red, white and yellow onions have been identified as the source of a multi-state outbreak, the CDC said.
U.S. ally Qatar condemns Israel for strikes targeting Hamas leaders in its capital city Doha, calling them "a blatant violation of all international laws and norms."
President Trump ordered the FDA to enforce rules on direct-to-consumer drug ads, after HHS Secretary Robert F. Kennedy Jr. released a report on the administration's approach to healthy outcomes for children and families.
The Supreme Court on Tuesday said it will decide whether President Trump can impose his most sweeping tariffs.
Democrat James Walkinshaw and Republican Stewart Whitson are facing off Tuesday in a Northern Virginia special House election to pick Rep. Gerry Connolly's successor.
President Trump's administration asked the Supreme Court on Monday to allow it to freeze billions of dollars in foreign aid funding.
The Justice Department charged the suspect, Decarlos Brown Jr., with one count of committing an act causing death on a mass transportation system.
In August, the Pentagon offered full military funeral honors to Jan. 6 rioter Ashli Babbitt, after denying her family's request for the honor in 2021.
Uncertainty over U.S. tariffs and other Trump administration economic policies are deterring manufacturers from hiring, according to the Center for American Progress.
The Drug Enforcement Administration said its efforts resulted in more than 600 arrests in operations targeting the Sinaloa drug cartel, which has been labeled a terrorist group.